
Phacovit
Aristopharma Ltd.
Sodium Succinate + Cytochrome C + Adenosine + Nicotinamide is a combination antihypoxant/metabolic-support preparation used mainly as an adjunctive treatment in conditions associated with tissue…
Sodium Succinate + Cytochrome C + Adenosine + Nicotinamide is a combination antihypoxant/metabolic-support preparation used mainly as an adjunctive treatment in conditions associated with tissue hypoxia and impaired cellular energy metabolism. It is not a first-line or curative therapy and does not replace standard emergency or disease-specific treatment.
Note: The evidence base for this specific four-component combination is limited and varies by region compared with conventional, guideline-directed therapies. It should be used only as directed by a physician and only as an adjunct, never as a substitute for standard emergency treatment of acute ischemic events.
Sodium Succinate + Cytochrome C + Adenosine + Nicotinamide is used strictly as directed by a physician, as an adjunct to standard treatment. Because commercial strengths, ampoule/vial sizes and recommended regimens vary by manufacturer and country, the dose and duration must be individualised and taken from the specific product's approved labelling; the information below is a general framework only.
| Indication | Typical adult approach | Notes |
|---|---|---|
| Adjunct in acute cerebral ischaemia/hypoxic-toxic encephalopathy | Slow intravenous infusion, once daily, for a limited course (commonly around 10 days), as prescribed | Given alongside standard stroke/encephalopathy management, not as a replacement |
| Adjunct in chronic cerebrovascular insufficiency/recovery phase | Course-based intravenous or, where available, oral/other administration as licensed locally | Repeat courses only on physician advice |
See Dosage and Administration below for further detail.
Reported side effects of Sodium Succinate + Cytochrome C + Adenosine + Nicotinamide include:
Contact your physician promptly if you notice breathing difficulty, swelling of the face/throat, severe dizziness, chest pain, or a marked change in heart rate after receiving Sodium Succinate + Cytochrome C + Adenosine + Nicotinamide.
Sodium Succinate + Cytochrome C + Adenosine + Nicotinamide is contraindicated in patients with known hypersensitivity to sodium succinate, cytochrome C, adenosine, nicotinamide, or any other component of the specific formulation being used.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.